A

Atossa Therapeutics
D

ATOS

0.84910
USD
0.01
(1.51%)
مغلق
حجم التداول
5,373
الربح لكل سهم
-0
العائد الربحي
-
P/E
-4
حجم السوق
109,678,250
أصول ذات صلة
A
AVXL
0.250
(2.37%)
10.790 USD
B
BKYI
-0.00990
(-1.21%)
0.81000 USD
D
DVAX
0.095
(0.94%)
10.250 USD
G
GNPX
0.00130
(0.49%)
0.26630 USD
I
IBIO
0.00500
(0.68%)
0.74000 USD
I
INO
-0.71500
(-33.49%)
1.42000 USD
N
NVAX
0.04000
(0.59%)
6.79000 USD
V
VXRT
-0.01110
(-2.53%)
0.42750 USD
المزيد
الأخبار المقالات

العنوان: Atossa Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.